- Available
- $47.33
- Reserved
- $175.07
Public accountability
Financials
Transactions and purchases
Reconciled activity · All amounts in SGD
- −$59.49
Milk Powder · Isomil Stage 3 · Isomil Stage 3
- Reference
- TX-26-15FC10
- −$41.06
Walking frame with front wheels
- Reference
- BB-26-222284
- +$50.00
Direct bank donation received
- Reference
- TX-26-EAF333
- −$105.79
Single mattresses
- Reference
- 161899
- −$61.90
Adult diapers L size Wrap & Fresubin Milk, Cappuccino Flavour
- Reference
- 158197
- −$66.00
Friso Gold Stage 3
- Reference
- 162073
- +$300.00
Direct bank donation received
- Reference
- TX-26-B27C73
- −$10.00
Bank charges – November 2026
- Reference
- TX-26-23E337
- −$23.63
Standing Fan
- Reference
- 161926
- +$100.00
Direct bank donation received
- Reference
- TX-26-F79240
| Date | Activity & documents | Reference | Amount |
|---|---|---|---|
| Milk Powder · Isomil Stage 3 · Isomil Stage 3 | TX-26-15FC10 | −$59.49 | |
| Walking frame with front wheels | BB-26-222284 | −$41.06 | |
| Direct bank donation received | TX-26-EAF333 | +$50.00 | |
| Single mattresses | 161899 | −$105.79 | |
| Adult diapers L size Wrap & Fresubin Milk, Cappuccino Flavour | 158197 | −$61.90 | |
| Friso Gold Stage 3 | 162073 | −$66.00 | |
| Direct bank donation received | TX-26-B27C73 | +$300.00 | |
| Bank charges – November 2026 | TX-26-23E337 | −$10.00 | |
| Standing Fan | 161926 | −$23.63 | |
| Direct bank donation received | TX-26-F79240 | +$100.00 |
Page 1 of 28 · 276 entries
Financial statement
Statement of Income & Expenditure for 1 Jan 2026 – 17 Nov 2026.
Structured to follow SFRS presentation conventions for transparency. This is a live, unaudited cash-basis view, not the signed annual filing.
Statement of Financial Position
Assets
Non-current assets
- FY 2026
- $0.00
- FY 2025
- $0.00
Cash and cash equivalents
- FY 2026
- $1,255.99
- FY 2025
- $2.56
Total assets
- FY 2026
- $1,255.99
- FY 2025
- $2.56
Liabilities
Current liabilities
- FY 2026
- $0.00
- FY 2025
- $0.00
Net assets
General fund (unrestricted)
- FY 2026
- $1,073.25
- FY 2025
- $2.56
Designated / earmarked funds (Note 2)
- FY 2026
- $182.74
- FY 2025
- $0.00
Total net assets
- FY 2026
- $1,255.99
- FY 2025
- $2.56
| Item | FY 2026 | FY 2025 |
|---|---|---|
| Assets | ||
| Non-current assets | $0.00 | $0.00 |
| Cash and cash equivalents | $1,255.99 | $2.56 |
| Total assets | $1,255.99 | $2.56 |
| Liabilities | ||
| Current liabilities | $0.00 | $0.00 |
| Net assets | ||
| General fund (unrestricted) | $1,073.25 | $2.56 |
| Designated / earmarked funds (Note 2) | $182.74 | $0.00 |
| Total net assets | $1,255.99 | $2.56 |
Statement of Income and Expenditure
Net assets, brought forward
- FY 2026
- $2.56
- FY 2025
- $275.93
Income
Donations
- FY 2026
- $7,315.92
- FY 2025
- $2,750.00
Fundraising (Note 2)
- FY 2026
- $2,438.74
- FY 2025
- $0.00
Interest income
- FY 2026
- $0.56
- FY 2025
- $1.83
Total income
- FY 2026
- $9,755.22
- FY 2025
- $2,751.83
Expenditure
Expenditure on charitable activities (Note 3)
- FY 2026
- $6,777.55
- FY 2025
- $3,025.20
Donation refunds
- FY 2026
- $1,674.24
- FY 2025
- $0.00
Administrative and operating expenses
- FY 2026
- $50.00
- FY 2025
- $0.00
Total expenditure
- FY 2026
- $8,501.79
- FY 2025
- $3,025.20
Surplus / (deficit) for the year
- FY 2026
- $1,253.43
- FY 2025
- -$273.37
Net assets, carried forward
- FY 2026
- $1,255.99
- FY 2025
- $2.56
| Item | FY 2026 | FY 2025 |
|---|---|---|
| Net assets, brought forward | $2.56 | $275.93 |
| Income | ||
| Donations | $7,315.92 | $2,750.00 |
| Fundraising (Note 2) | $2,438.74 | $0.00 |
| Interest income | $0.56 | $1.83 |
| Total income | $9,755.22 | $2,751.83 |
| Expenditure | ||
| Expenditure on charitable activities (Note 3) | $6,777.55 | $3,025.20 |
| Donation refunds | $1,674.24 | $0.00 |
| Administrative and operating expenses | $50.00 | $0.00 |
| Total expenditure | $8,501.79 | $3,025.20 |
| Surplus / (deficit) for the year | $1,253.43 | -$273.37 |
| Net assets, carried forward | $1,255.99 | $2.56 |
1. Basis of preparation. Cash is recognised when received and expenditure when paid. The statement begins on 18 September 2025. Opening balances are calculated from recorded ledger entries before the selected period.
2. Basis of presentation. Operating funds are unrestricted; beneficiary-purpose funds are shown as designated or earmarked net assets rather than liabilities.
3. Expended total. Charitable activity includes posted beneficiary purchases within the selected financial year.
